Luciana Basili Dias Candidíase vulvovaginal em pacientes gestantes

Referências Bibliográficas 91
Fevi-Walboso PA, Amadi AN. The Prevalence and Pattern of Vaginal Candidiasis in Pregnancy
in Alba. Jnl of Medicla Investigation and Practice. 2001; 2: 25-7.
Fidel PL. Distinct Protective Host Defenses Against Oral and Vaginal Candidiasis. Med. Mycol.
2002; 40: 359-75.
Fidel PL, Sobel JD. Protective immunity in esperimental Candida vaginitis. Rev Immunol. 1998;
149: 361-73.
Filippin FB, Souza LC. Eficiência terapêutica das formulações lipídicas de anfotericina B. Rev.
Bras. Cienc. Farm. 2006; 42: 167-94.
Fotedar R, Al-Hedaithy SSA. Identification chlamydospore-negative Candida albicans using
CHROMagar Candida medium. Mycoses. 2002; 46: 96-103.
Franzot SP, Hamdan JS. Effects of three azole derivatives on the lipids of different strains of
Cryptococcus neoformans. Mycoses. 1995; 38: 183-9.
Fromtling RA, Galgiani JN, Pfaller MA, Espinel-Ingroff A, Bartizal KF, Bartlett MS.
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeast.
Antimicrob Agents Chemother.1993; 37: 39-45.
Galgiani JN, Stevens DA. Antimicrobial Susceptibility Testing of yeast: a Turbidimetric
Technique Independent of Inoculum Size. Antimicrob Agents Chemother. 1976; 10: 721-6.
Galle LC, Gianinni MJSM. Prevalência e susceptibilidade de leveduras vaginais. J. Bras. Patol.
Med. Lab. 2004; 40: 229-36.
Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev.
Infect. Dis. 1990; 12: 308-29.
Garcia Heredia M, Garcia SD, Copolillo EF, Cora Eliseth M, Barata AD, Vay CA, et al.
Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility
to antifungal agents. Rev Argent Microbiol. 2006; 38: 9-12.